Financials

  • Market Capitalization 2.06 B
  • Employee 167
  • Founded 2019
  • CEO N/A
  • Website www.zenasbio.com
  • Headquarter Delaware, United States
  • FIGI BBG01J1MG9D6
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.3
Relación precio/flujo de caja
162.41

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1975
ADMA
ADMA Biologics Inc - Common Stock
9.41 USD-0.74%-4.85%+8.04%-45.92%2.11 B USD
1980
XNCR
Xencor, Inc. - Common Stock
27.19 USD-5.85%-2.05%+36.43%+235.68%2.02 B USD
1982
MRVI
Maravai LifeSciences Holdings, Inc. - Class A common stock
7.89 USD-5.73%-9.62%+15.52%+231.51%2.05 B USD
1993
STOK
Stoke Therapeutics, Inc. - Common Stock
31.93 USD-2.03%-2.00%+8.49%+59.65%2.06 B USD